Search Results - Aik Choon Tan

Refine Results
  1. 1

    1231 Exploring the landscape of pan-cancer immune-related adverse events through clinical trials big data mining by Aik Choon Tan, Muhammad Z Fadlullah Wilmot

    Published in Journal for ImmunoTherapy of Cancer (2023-11-01)
    Article


  2. 2

    Editorial: AI and data science in drug development and public health: Highlights from the MCBIOS 2022 conference by Ramin Homayouni, Prashanti Manda, Aik Choon Tan, Zhaohui S. Qin

    Published in Frontiers in Big Data (2023-02-01)
    Get full text
    Article


  3. 3

    A Survey of Computational Tools to Analyze and Interpret Whole Exome Sequencing Data by Jennifer D. Hintzsche, William A. Robinson, Aik Choon Tan

    Published in International Journal of Genomics (2016-01-01)
    Get full text
    Article


  4. 4

    iCOSSY: An Online Tool for Context-Specific Subnetwork Discovery from Gene Expression Data. by Ashis Saha, Minji Jeon, Aik Choon Tan, Jaewoo Kang

    Published in PLoS ONE (2015-01-01)
    Get full text
    Article


  5. 5

    Parkinsons Disease-related Circulating microRNA Biomarkers——a Validation Study by David Petillo, Stephen Orey, Aik Choon Tan, Lars Forsgren, Sok Kean Khoo

    Published in AIMS Medical Science (2015-02-01)
    Get full text
    Article


  6. 6

    Systems Pharmacology-Based Approach of Connecting Disease Genes in Genome-Wide Association Studies with Traditional Chinese Medicine by Jihye Kim, Minjae Yoo, Jimin Shin, Hyunmin Kim, Jaewoo Kang, Aik Choon Tan

    Published in International Journal of Genomics (2018-01-01)
    Get full text
    Article


  7. 7

    Comparative Haploid Genetic Screens Reveal Divergent Pathways in the Biogenesis and Trafficking of Glycophosphatidylinositol-Anchored Proteins by Eric M. Davis, Jihye Kim, Bridget L. Menasche, Jacob Sheppard, Xuedong Liu, Aik-Choon Tan, Jingshi Shen

    Published in Cell Reports (2015-06-01)
    Get full text
    Article


  8. 8

    Downregulated <i>ALDH2</i> Contributes to Tumor Progression and Targeted Therapy Resistance in Human Metastatic Melanoma Cells by Zili Zhai, Takeshi Yamauchi, Karenna Sandoval, Kira Villarreal, Man Wai Charlotte Kwong, Emily J. Swanson, Aik Choon Tan, Mayumi Fujita

    Published in Cells (2025-06-01)
    Get full text
    Article


  9. 9

    DRPPM-EASY: A Web-Based Framework for Integrative Analysis of Multi-Omics Cancer Datasets by Alyssa Obermayer, Li Dong, Qianqian Hu, Michael Golden, Jerald D. Noble, Paulo Rodriguez, Timothy J. Robinson, Mingxiang Teng, Aik-Choon Tan, Timothy I. Shaw

    Published in Biology (2022-02-01)
    Get full text
    Article


  10. 10

    An Epigenomic fingerprint of human cancers by landscape interrogation of super enhancers at the constituent level. by Xiang Liu, Nancy Gillis, Chang Jiang, Anthony McCofie, Timothy I Shaw, Aik-Choon Tan, Bo Zhao, Lixin Wan, Derek R Duckett, Mingxiang Teng

    Published in PLoS Computational Biology (2024-02-01)
    Get full text
    Article


  11. 11

    Gene partners of the EWSR1 fusion may represent molecularly distinct entities by Victoria Walker, Dexter X. Jin, Sherri Z. Millis, Elham Nasri, Diana A. Corao-Uribe, Aik Choon Tan, Brooke L. Fridley, James L. Chen, Nathan D. Seligson

    Published in Translational Oncology (2023-12-01)
    Get full text
    Article


  12. 12

    Drepmel—A Multi-Omics Melanoma Drug Repurposing Resource for Prioritizing Drug Combinations and Understanding Tumor Microenvironment by Zachary J. Thompson, Jamie K. Teer, Jiannong Li, Zhihua Chen, Eric A. Welsh, Yonghong Zhang, Noura Ayoubi, Zeynep Eroglu, Aik Choon Tan, Keiran S. M. Smalley, Yian Ann Chen

    Published in Cells (2022-09-01)
    Get full text
    Article


  13. 13

    <i>PARP1</i> and <i>POLD2</i> as prognostic biomarkers for multiple myeloma in autologous stem cell transplant by Melissa Thomas, Junan Li, Kevan King, Avinash K Persaud, Ernest Duah, Zachary Vangundy, Craig C. Hofmeister, Jatinder K. Lamba, Aik Choon Tan, Brooke L. Fridley, Ming J. Poi, Nathan D. Seligson

    Published in Haematologica (2023-03-01)
    Get full text
    Article


  14. 14

    A tyrosine kinase inhibitor-induced interferon response positively associates with clinical response in EGFR-mutant lung cancer by Natalia J. Gurule, Caroline E. McCoach, Trista K. Hinz, Daniel T. Merrick, Adriaan Van Bokhoven, Jihye Kim, Tejas Patil, Jacob Calhoun, Raphael A. Nemenoff, Aik Choon Tan, Robert C. Doebele, Lynn E. Heasley

    Published in npj Precision Oncology (2021-05-01)
    Get full text
    Article


  15. 15

    PATH-SURVEYOR: pathway level survival enquiry for immuno-oncology and drug repurposing by Alyssa N. Obermayer, Darwin Chang, Gabrielle Nobles, Mingxiang Teng, Aik-Choon Tan, Xuefeng Wang, Y. Ann Chen, Steven Eschrich, Paulo C. Rodriguez, G. Daniel Grass, Soheil Meshinchi, Ahmad Tarhini, Dung-tsa Chen, Timothy I. Shaw

    Published in BMC Bioinformatics (2023-06-01)
    Get full text
    Article


  16. 16

    Grading of lung adenocarcinomas with simultaneous segmentation by artificial intelligence (GLASS-AI) by John H. Lockhart, Hayley D. Ackerman, Kyubum Lee, Mahmoud Abdalah, Andrew John Davis, Nicole Hackel, Theresa A. Boyle, James Saller, Aysenur Keske, Kay Hänggi, Brian Ruffell, Olya Stringfield, W. Douglas Cress, Aik Choon Tan, Elsa R. Flores

    Published in npj Precision Oncology (2023-07-01)
    Get full text
    Article


  17. 17

    Real-world pan-cancer landscape of frameshift mutations and their role in predicting responses to immune checkpoint inhibitors in cancers with low tumor mutational burden by Ignacio Garrido-Laguna, Asaf Maoz, Wungki Park, Abdul Rafeh Naqash, Vaia Florou, Breelyn Wilky, Jonathan Trent, Umang Swami, Garrett Frampton, Heloisa P Soares, Sonam Puri, Aik Choon Tan, Charalampos S Floudas, Carter Norton, Ethan S Sokol, Peter Hosein, Gilberto de Lima Lopes

    Published in Journal for ImmunoTherapy of Cancer (2023-08-01)
    Get full text
    Article


  18. 18

    Antitumor activity of the polo-like kinase inhibitor, TAK-960, against preclinical models of colorectal cancer by Peter J. Klauck, Stacey M. Bagby, Anna Capasso, Erica L. Bradshaw-Pierce, Heather M. Selby, Anna Spreafico, John J. Tentler, Aik Choon Tan, Jihye Kim, John J. Arcaroli, Alicia Purkey, Wells A. Messersmith, Keisuke Kuida, S. Gail Eckhardt, Todd M. Pitts

    Published in BMC Cancer (2018-02-01)
    Get full text
    Article


  19. 19

    Dramatic Responses to High-Dose Ipilimumab Plus Temozolomide After Progression on Standard- or Low-Dose Ipilimumab in Advanced Melanoma by Julie Williamson, Muhammad Zaki Hidayatullah Fadlullah, Magdalena Kovacsovics-Bankowski, Berit Gibson, Umang Swami, Alyssa Erickson-Wayman, Debra Jamison, Dan Sageser, Joanne Jeter, Tawnya L. Bowles, Donald M. Cannon, Ben Haaland, Joyce D. Schroeder, David A. Nix, Aaron Atkinson, John Hyngstrom, Jordan McPherson, Aik-Choon Tan, Siwen Hu-Lieskovan

    Published in Current Oncology (2025-02-01)
    Get full text
    Article


  20. 20

    Phase II trial of pembrolizumab, ipilimumab, and aspirin in melanoma: clinical outcomes and translational predictors of response by Zoe Quandt, Saya Jacob, Muhammad Zaki Hidayatullah Fadlullah, Chaorong Wu, Clinton Wu, Laura Huppert, Lauren S. Levine, Paula Sison, Katy K. Tsai, Melissa Chow, Jee Hye Kang, Jimmy Hwang, James C. Lee, Ariel Oglesby, Jessica Venegas, Ben J. Brintz, Aik Choon Tan, Mark S. Anderson, Michael D. Rosenblum, Arabella Young, Adil I. Daud

    Published in BJC Reports (2024-06-01)
    Get full text
    Article


Search Tools: